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Analytical data for 4F-MDMB-BINACA Recovered from paper sample FL19/0077-1 
 















1H NMR (500 MHz, Chloroform-d) δ 8.37 (d, J = 8.2 Hz, 1H), 7.57 (d, J = 9.7 Hz, 1H), 7.49 – 
7.39 (m, 2H), 7.32 – 7.29 (m, 1H), 4.75 (d, J = 9.7 Hz, 1H), 4.52 (dt, J = 47.2, 5.7 Hz,  2H), 4.50 
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13C NMR (126 MHz, Chloroform-d) δ 172.33, 162.40, 140.98, 137.00, 126.97, 123.05, 123.00, 
122.84, 109.25, 83.63 (d, J = 165.3 Hz), 59.61, 51.98, 49.01, 35.19, 27.79 (d, J = 20.1 Hz), 26.82, 
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(b) UPLC-QToF-MS Data – Recovered 4F-MDMB-BINACA 
(i) Low energy (6V) TOF-MS spectrum 
 
 



















A: Synthesis of (S)- 4F-MDMB-BINACA  
Synthesis of the first intermediate  
The first intermediate was prepared using the method reported by Banister et al.1,2. Methyl-1H-
indazole-3-carboxylate (5.68 mmol) was dissolved in tetrahydrofuran (30 mL) in a dried and ice-
cooled round-bottom flask. To this was added potassium tert-butoxide (6.24 mmol, 1.1 eq). The 
ice bath was removed, and the mixture was stirred for 1 hour. Subsequently, the mixture was 
cooled again, and pre-requisite alkyl halide was dropwise added (5.96 mmol, 1.05 eq). The 
resulting solution was stirred for 48 hours at ambient temperature. Hereafter, the reaction was 
quenched with water (100 mL) and extracted with ethyl acetate (3 x 100 mL). The organic layers 
were combined, washed with brine (150 mL), dried with magnesium sulfate and concentrated in 
vacuo. The resulting yellow-orange oil (which crystallised upon standing), was purified using flash 
column chromatography, using a mobile phase of hexane-ethyl acetate (80:20 v/v).   
 
Synthesis of the second intermediate  
The second intermediate was prepared using the method reported by Banister et al.1,2. The first 
intermediate (2.58 mmol) was dissolved in methanol (20 mL) and a 1 M aqueous sodium 
hydroxide solution (3.78 mmol, 1.5 eq) was added. The resulting solution was heated to a reflux 
and stirred for 18 hours. Here after, the mixture was cooled to room temperature, and concentrated 
in vacuo. The remaining solid was suspended it a saturated aqueous sodium bicarbonate solution 
(75 mL) and washed with diethyl ether (75 mL). Subsequently, the pH of the aqueous phase was 
adjusted to 2 with a 1M aqueous hydrochloric acid solution. The acidified aqueous phase was 
extracted with diethyl ether (3 x 75 mL). The organic layers were combined, washed with brine 
(150 mL), dried with magnesium sulfate and concentrated in vacuo. If necessary, the resulting 
solid was recrystallised from isopropanol.   
 
Synthesis of the final compounds  
(S)-4F-MDMB-BINACA were prepared using the method reported by Banister et al.1,2. The 
second intermediate (0.78 mmol) was dissolved in dimethylsulfoxide (10 mL) in a round-bottom 
flask. To this was added (S)-tert leucine methyl ester (0.82 mmol, 1.05 eq), EDC*HCl (1.56 mmol, 
2 eq), HOBt, (1.56 mmol, 2 eq) and finally, DIPEA (3.9 mmol, 5 eq) was dropwise added. The 
resulting solution was stirred for 14 hours at ambient temperature. Hereafter, the reaction was 
quenched with a saturated aqueous sodium bicarbonate solution (75 mL), and extracted with ethyl 
acetate (3 x 75 mL). The organic layers were combined, washed with brine (100 mL), dried with 
magnesium sulfate and concentrated in vacuo. The resulting yellow-orange oil was purified using 
flash column chromatography, using a mobile phase of hexane-ethyl acetate (80:20 v/v). 
 
B: Synthesis of (S)-5F-MDMB-PICA and (S)-AMB-CHMICA 
Synthesis of the first intermediate  
The first intermediate of the indole carboxamide type SCRAs were prepared using the method 
reported by Banister et al. (1,2) Sodium hydride (60% dispersion in mineral oil, 1.37 g, 34.2 mmol, 
2 eq) was suspended in cooled (0 °C) dimethylformamide (60 mL). Indole (2 g, 17.1 mmol) was 
portion wise added. This mixture was stirred for 10 minutes at ambient temperature. Hereafter, the 
mixture was cooled again and the appropriate bromoalkane (18.0 mmol, 1.05 eq) was dropwise 
added after which the mixture was stirred for 1 hour at ambient temperature. The mixture was 
cooled again and trifluoroacetic anhydride (5.9 mL, 42.8 mmol, 2.5 eq) was dropwise added and 
was stirred for 1 hour at ambient temperature. To quench the reaction, the mixture was poured 
onto ice water (150 mL) and extracted with dichloromethane ( 3 x 100 mL). The organic phase 
was washed with water (2 x 100 mL) and brine (150 mL), dried using magnesium sulfate and 
concentrated in vacuo. The resulting oil was purified using flash column chromatography, using a 
mobile phase of hexane-ethyl acetate (90:10 v/v).  
 
 
Synthesis of the second intermediate 
The second intermediate of indole carboxamide-type SCRAs were prepared using an adaptation 
of the method reported Corbet (patent US20040067939). The first intermediate (the alkyl indole) 
(4.98 mmol) was dissolved in an aqueous sodium hydroxide solution (20%, 20 mL). The mixture 
was heated till reflux and stirred for 18 hour. The resulting mixture was cooled the reaction was 
quenched by adding water (150 mL). The pH was adjusted to 1 using 1 M aqueous hydrochloric 
acid (10 mL). The water phase was extracted using ethyl acetate (2 x 150 mL). The combined 
organic layers were washed with saturated aqueous sodium hydrogen carbonate (100 mL), water 
(100 mL) and brine (100 mL), then dried using magnesium sulfate and concentrated in vacuo. The 
resulting solid was recrystallized from diethyl ether. 
 
Synthesis of the final compound 
The final compound of indole carboxamide-type SCRAs were prepared using the method reported 
by Banister et al.1,2.The second intermediate (0.78 mmol) was dissolved in dimethylsulfoxide (10 
mL) in a round-bottom flask. To this was added the pre-requisite amino acid derivative (0.82 
mmol, 1.05 eq), EDC*HCl (1.56 mmol, 2 eq), HOBt, (1.56 mmol, 2 eq) and finally, DIPEA (3.9 
mmol, 5 eq) was dropwise added. The resulting solution was stirred for 14 hours at ambient 
temperature. Hereafter, the reaction was quenched with a saturated aqueous sodium bicarbonate 
solution (75 mL), and extracted with ethyl acetate (3 x 75 mL). The organic layers were combined, 
washed with brine (100 mL), dried with magnesium sulfate and concentrated in vacuo. The 
resulting yellow-orange oil was purified using flash column chromatography, using a mobile phase 
of hexane-ethyl acetate (80:20 v/v) for 5F-MDMB-PICA. The compound AMB-CHMICA was 
purified with hexane-ethyl acetate (90:10 v/v). 
 
References 
1Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, et al. Pharmacology of 
Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-
FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues. ACS Chemical 
Neuroscience. 2016;7(9):1241-54. 
 
2Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, et al. Pharmacology of Indole 
and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-
PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. 
ACS Chemical Neuroscience. 2015;6(9):1546-59.  
  
C: Analytical characterisation data  
 
(S)-4F-MDMB-BINACA  
1H-NMR (400 MHz, CHLOROFORM-D) δ 8.32-8.35 (m, 1H), 7.53 (d, J = 9.6 Hz, 1H), 7.41 
(td, J = 2.4, 1.1 Hz, 2H), 7.27 (q, J = 2.6 Hz, 1H), 4.72 (d, J = 9.6 Hz, 1H), 4.54 (t, J = 5.7 Hz, 
1H), 4.46 (t, J = 7.1 Hz, 2H), 4.42 (t, J = 5.7 Hz, 1H), 3.75 (s, 3H), 2.07-2.15 (m, 2H), 1.68-1.78 
(m, 2H), 1.10 (d, J = 13.3 Hz, 9H) 
13C-NMR (101 MHz, CHLOROFORM-D) δ 172.26 (s, 1C), 162.34 (s, 1C), 140.94 (s, 1C), 
136.97 (s, 1C), 126.91 (s, 1C), 123.05-122.98 (1C), 122.95 (s, 1C), 122.78 (s, 1C), 109.18 (s, 
1C), 83.55 (d, J = 165.3 Hz, 1C), 59.57 (s, 1C), 51.89 (s, 1C), 48.95 (s, 1C), 35.13 (s, 1C), 27.73 
(d, 1C), 26.76 (s, 3C), 25.95 (d, 1C) 
GC-MS tR = 15.42 min, m/z = 363[M+], 219 (100%), 145 (31%), 275 (26%), 307 (25%), 131 
(23%) 
Yield: 91.0%, purity: 99.7 % 
 
(S)-5F-MDMB-PICA 
1H-NMR (400 MHz, CHLOROFORM-D) δ (ppm) 7.95-7.98 (m, 1H), 7.74 (s, 1H), 7.37-7.39 
(m, 1H), 7.27-7.30 (m, 2H), 6.52 (d, J = 9.2 Hz, 1H), 4.77 (d, J = 9.2 Hz, 1H), 4.41 (dt, J = 47.2, 
6.0 Hz, 2H), 4.16 (t, J = 7.1 Hz, 2H), 3.75 (s, 3H), 1.87-1.95 (m, 2H), 1.66-1.76 (m, 2H), 1.43-
1.49 (m, 2H), 1.08 (s, 9H) 
13C-NMR (101 MHz, CHLOROFORM-D) δ (ppm) 172.82 (s, 1C), 164.81 (s, 1C), 136.65 (s, 
1C), 131.98 (s, 1C), 125.32 (s, 1C), 122.62 (s, 1C), 121.78 (s, 1C), 120.07 (s, 1C), 110.75 (s, 
1C), 110.41 (s, 1C), 83.76 (d, J = 165.3 Hz, 1C), 59.78 (s, 1C), 51.96 (s, 1C), 46.83 (s, 1C), 
35.16 (s, 1C), 30.04 (d, 1C), 29.74 (s, 1C), 26.85 (s, 3C), 22.92 (d, 1C) 
GC-MS tR = 17.02 min, m/z = 376[M+], 232 (100%), 144 (20%), 233 (17%), 260 (10%), 288 
(8%) 
Yield: 87.9%, purity: 98.7+% 
 
(S)-AMB-CHMICA 
1H-NMR (400 MHz, CHLOROFORM-D) δ (ppm) 7.95-7.99 (m, 1H), 7.70 (s, 1H), 7.37 (td, J = 
4.5, 3.1 Hz, 1H), 7.25-7.29 (m, 2H), 6.47 (d, J = 8.7 Hz, 1H), 4.86 (q, J = 4.4 Hz, 1H), 3.95 (d, J 
= 6.9 Hz, 2H), 3.78 (s, 3H), 2.27-2.32 (m, 1H), 1.82-1.88 (m, 1H), 1.64-1.71 (m, 5H), 1.15 (dd, J 
= 17.6, 9.4 Hz, 3H), 0.94-1.19 (m, 11H), 1.03 (dd, J = 9.6, 6.9 Hz, 6H) 
13C-NMR (101 MHz, CHLOROFORM-D) δ (ppm) 173.27 (s, 1C), 165.04 (s, 1C), 137.03 (s, 
1C), 132.67 (s, 1C), 122.44 (s, 1C), 121.59 (s, 1C), 120.05 (s, 2C), 110.73 (s, 2C), 56.94 (s, 1C), 
53.49 (s, 1C), 52.30 (s, 1C), 38.61 (s, 1C), 31.82 (s, 1C), 31.07 (s, 2C), 26.27 (s, 1C), 25.71 (s, 
2C), 19.20 (s, 1C), 18.17 (s, 1C) 
GC-MS tR = 18.16 min, m/z = 370[M+], 240 (100%), 256 (61%), 144 (31%), 207 (17%), 55 
(15%) 
Yield: 87.3%, purity: 99.6 % 
 
(S)-MDMB-4en-PINACA 
1H-NMR (400 MHz, CHLOROFORM-D) δ (ppm) 8.33 (d, J = 7.8 Hz, 1H), 7.55 (d, J = 9.6 Hz, 
1H), 7.47-7.32 (m, 2H), 7.32-7.16 (m, 1H), 5.91-5.70 (m, 1H), 5.14-4.95 (m, 2H), 4.72 (d, J = 
9.6 Hz, 1H), 4.40 (t, J = 6.6 Hz, 2H), 3.75 (s, 3H), 2.19-2.04 (m, 4H), 1.08 (s, 9H) 
13C-NMR (400 MHz, CHLOROFORM-D) δ (ppm) 172.28 (s, 1C), 162.42 (s, 1C), 140.93 (s, 
1C), 137.14 (s, 1C), 136.78 (s, 1C), 126.73 (s, 1C), 122.97 (s, 1C), 122.87 (s, 1C), 122.69 (s, 
1C), 116.02 (s, 1C), 109.31 (s, 1C), 59.53 (s, 1C), 51.92 (s, 1C), 48.69 (s, 1C), 35.14 (s, 1C), 
30.82 (s, 1C), 28.81 (s, 1C), 26.77 (s, 3C) 
GC-MS tR: 15.38 min, m/z = 356[M+], 213 (100%), 145 (28%), 171 (17%), 214 (17%), 301 
(16%). 
























Method development data, quantitative calculations, example calibration curves and 
quality assurance data. 
 
 
Figure S3.1a Analysis of SCRAs using a variety of solvents on GC-MS fitted with a HP-5MS 
column (n=10). 0.2 mg/mL solutions of an AMB-FUBINACA reference standard were made in 
each solvent. Hexane was immediately eliminated as the SCRA was not soluble in hexane. The 
remaining standards were injected ten times with the samples mixed up in the sequence in order 
to better account for the variability of the GC-MS, such as variability in the injection, inlet, solid 
phase, or MS source. The samples were run using a 1:20 split injection. Error bars reflect the 






































Figure S3.2. Variability of GC-MS peak area of SCRAs in DCM based on period of time 
(evaporation time) between first and last injection of a 0.2 mg/mL AMB-FUBINACA reference 
standard (n=10). 
 
Table S3.1. Determination of the number of extractions required to remove 100% of the SCRAs from paper using spiked paper samples. 
 
 4F-MDMB-BINACA 5F-MDMB-PINACA AMB-FUBINACA 5F-MDMB-PICA AMB-CHMICA 
Sample Extraction Peak Area % of Total 
Peak Area 
Peak Area % of Total 
Peak Area 
Peak Area % of Total 
Peak Area 
Peak Area % of Total 
Peak Area 
Peak Area % of Total 
Peak Area 
1 
1 6199921 98.19 6477579 98.43 6623660 98.43 6888002 95.42 8007152 95.09 
2 114177 1.81 99324 1.51 102438 1.52 311600 4.32 397461 4.72 
3 0 0.00 3897 0.06 2983 0.04 19374 0.27 16351 0.19 
4 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
5 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
2 
1 6120132 96.51 7144536 94.16 7356744 94.32 5549749 96.50 6652830 96.52 
2 205353 3.24 420607 5.54 420591 5.39 196400 3.41 237924 3.45 
3 15902 0.25 22145 0.29 22594 0.29 5080 0.09 2085 0.03 
4 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
5 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
3 
1 5854229 96.77 6783245 98.29 7044574 98.29 6224384 97.29 7346622 97.28 
2 187689 3.10 110705 1.60 115883 1.62 166643 2.60 202063 2.68 
3 7407 0.12 7159 0.10 6681 0.09 6861 0.11 3625 0.05 
4 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 













2 2.72 2.89 2.84 3.45 3.62 
3 0.12 0.15 0.14 0.15 0.09 
4 0.00 0.00 0.00 0.00 0.00 











Calculations for the Quantitation of SCRA Paper Samples 
 
CALIBRATION STANDARD CONCENTRATION CALCULATIONS 
1. Calculate the 1 mg/mL SCRA Concentration 
MeOH Volume = 𝑔𝑔 𝑜𝑜𝑜𝑜 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝜌𝜌 𝑜𝑜𝑜𝑜 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
 




2. Calculate the Internal Standard (IS) Concentration 





[378 µg/mL IS] = (𝑔𝑔 𝑜𝑜𝑜𝑜 𝐼𝐼𝑆𝑆 𝑆𝑆𝑆𝑆𝑜𝑜𝑇𝑇𝑆𝑆) × [𝐼𝐼𝑆𝑆 𝑆𝑆𝑆𝑆𝑜𝑜𝑇𝑇𝑆𝑆][𝐼𝐼𝑆𝑆 𝑆𝑆𝑆𝑆𝑜𝑜𝑇𝑇𝑆𝑆]+ 𝜌𝜌 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆  ÷  � 
𝑔𝑔 𝑜𝑜𝑜𝑜 𝐼𝐼𝑆𝑆 𝑆𝑆𝑆𝑆𝑜𝑜𝑇𝑇𝑆𝑆
[𝐼𝐼𝑆𝑆 𝑆𝑆𝑆𝑆𝑜𝑜𝑇𝑇𝑆𝑆]+ 𝜌𝜌 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆




3. Calculate the Calibration Standards Volumes 
SCRA Volume = 𝑔𝑔 𝑜𝑜𝑜𝑜 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆[𝑚𝑚𝑔𝑔/𝑚𝑚𝑚𝑚 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆] + 𝜌𝜌 𝑜𝑜𝑜𝑜 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 
IS Volume = 𝑔𝑔 𝑜𝑜𝑜𝑜 378 𝜇𝜇𝑔𝑔/𝑚𝑚𝑚𝑚 𝐼𝐼𝑆𝑆 
[378 𝜇𝜇𝑔𝑔/𝑚𝑚𝑚𝑚 𝐼𝐼𝑆𝑆] +𝜌𝜌 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆
 
DCM Volume = 𝑔𝑔 𝑜𝑜𝑜𝑜 𝐷𝐷𝑆𝑆𝑀𝑀
𝜌𝜌 𝑜𝑜𝑜𝑜 𝐷𝐷𝑆𝑆𝑀𝑀
 
Solvent Volume = 𝑔𝑔 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆
𝜌𝜌 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆
 
Total Volume = SCRA Volume + IS Volume + DCM Volume + Solvent Volume 
 
4. Calculate the Calibration Standards Actual Concentrations 
[SCRA] = 𝑉𝑉𝑜𝑜𝑉𝑉𝑉𝑉𝑚𝑚𝑀𝑀 𝑜𝑜𝑜𝑜 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆
𝑇𝑇𝑜𝑜𝑆𝑆𝑇𝑇𝑉𝑉 𝑉𝑉𝑜𝑜𝑉𝑉𝑉𝑉𝑚𝑚𝑀𝑀
× [𝑚𝑚𝑚𝑚/𝑚𝑚𝐿𝐿 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆] 
[IS] = 𝑉𝑉𝑜𝑜𝑉𝑉𝑉𝑉𝑚𝑚𝑀𝑀 𝑜𝑜𝑜𝑜 𝐼𝐼𝑆𝑆
𝑇𝑇𝑜𝑜𝑆𝑆𝑇𝑇𝑉𝑉 𝑉𝑉𝑜𝑜𝑉𝑉𝑉𝑉𝑚𝑚𝑀𝑀
× [378 𝜇𝜇𝑚𝑚/𝑚𝑚𝐿𝐿 𝐼𝐼𝑆𝑆] 
 
5. Calculate the Average Internal Standards Concentration for All Standards 
6. Calculate the Response Ratio and Concentration Ratio of Calibration Responses 
Response Ratio = 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑆𝑆𝑀𝑀𝑠𝑠𝑅𝑅𝑜𝑜𝑇𝑇𝑠𝑠𝑀𝑀
 𝐼𝐼𝑆𝑆 𝑆𝑆𝑀𝑀𝑠𝑠𝑅𝑅𝑜𝑜𝑇𝑇𝑠𝑠𝑀𝑀
 




7. Calculate the Average Response Ratios of Each Calibration Standard 
8. Calculate a Quadratic Regression for the Calibration Curve Using Average Response Ratios 





� [Σ𝑐𝑐𝑇𝑇2𝑟𝑟𝑇𝑇 Σ𝑐𝑐𝑇𝑇𝑟𝑟𝑇𝑇 Σ𝑟𝑟𝑇𝑇] =  [𝑎𝑎 𝑏𝑏 𝑐𝑐]  
where y = ax2 +bx + c 
 
9. Calculate the Coefficient of Determination (R2) 
R2 = 1 − 𝑆𝑆𝑆𝑆𝑆𝑆
𝑆𝑆𝑆𝑆𝑇𝑇𝑀𝑀




where predictions are found by inputting each concentration ratio value into the quadratic 
regression. 
 
Method Validation Calculations 
10. Calculate the Check Standards Volumes 
Same as for Calibration Standards (Step 3) 
 
11. Calculate the Check Standards Actual Concentrations 
Same as for Calibration Standards (Step 4) 
 
12. Calculate the Response Ratios of Check Standards and Spiked Sample  




13. Calculate the Concentration Ratios of Check Standards and Spiked Sample 




For the check standards, use the average response ratio of the three runs of each standard. 
 
14. Calculate the µg/mL Concentration of Check Standards and Spiked Sample 
[Check Standard] = (𝑆𝑆𝐶𝐶𝑛𝑛𝑐𝑐𝐶𝐶𝑛𝑛𝐶𝐶𝑟𝑟𝑎𝑎𝐶𝐶𝐶𝐶𝐶𝐶𝑛𝑛 𝑆𝑆𝑎𝑎𝐶𝐶𝐶𝐶𝐶𝐶) × [𝐼𝐼𝑆𝑆] 
[Spiked Sample] = (𝑆𝑆𝐶𝐶𝑛𝑛𝑐𝑐𝐶𝐶𝑛𝑛𝐶𝐶𝑟𝑟𝑎𝑎𝐶𝐶𝐶𝐶𝐶𝐶𝑛𝑛 𝑆𝑆𝑎𝑎𝐶𝐶𝐶𝐶𝐶𝐶) × [𝐼𝐼𝑆𝑆] × 2, where 2 is the dilution factor 
 
 
15. Calculate the µg/cm2 Concentration of the Spiked Sample 
[µg/cm2] = [𝜇𝜇𝑚𝑚/𝑚𝑚𝐿𝐿] × 𝑉𝑉𝑜𝑜𝑉𝑉𝑉𝑉𝑚𝑚𝑀𝑀 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆 𝑇𝑇𝑇𝑇 𝑚𝑚𝑚𝑚
𝑆𝑆𝑇𝑇𝑀𝑀𝑇𝑇 𝑜𝑜𝑜𝑜 𝑅𝑅𝑇𝑇𝑅𝑅𝑀𝑀𝑇𝑇 𝑠𝑠𝑇𝑇𝑚𝑚𝑅𝑅𝑉𝑉𝑀𝑀 𝑇𝑇𝑇𝑇 𝑇𝑇𝑚𝑚2




16. Calculate the Percent Error of Check Standards and Spiked Sample 
% Error = �𝑆𝑆ℎ𝑀𝑀𝑜𝑜𝑇𝑇𝑀𝑀𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇𝑉𝑉−𝑇𝑇𝑇𝑇𝑆𝑆𝑉𝑉𝑇𝑇𝑉𝑉
𝑇𝑇𝑇𝑇𝑆𝑆𝑉𝑉𝑇𝑇𝑉𝑉
� × 100 
 
C: Calculating SCRA concentrations in paper samples (3mm hole punched samples) 
17. Calculate the Response Ratio and Concentration Ratio 
Same as for Check Standards (Step 9) 
 
18. Calculate the µg/mL Concentration 
[µg/mL] = (𝑆𝑆𝐶𝐶𝑛𝑛𝑐𝑐𝐶𝐶𝑛𝑛𝐶𝐶𝑟𝑟𝑎𝑎𝐶𝐶𝐶𝐶𝐶𝐶𝑛𝑛 𝑆𝑆𝑎𝑎𝐶𝐶𝐶𝐶𝐶𝐶) × [𝐼𝐼𝑆𝑆] × 2 
where 2 is the dilution factor 
 
19. Calculate the mg/cm2 Concentration 
[mg/cm2] = [𝜇𝜇𝑚𝑚/𝑚𝑚𝐿𝐿] × 𝑉𝑉𝑜𝑜𝑉𝑉𝑉𝑉𝑚𝑚𝑀𝑀 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑉𝑉𝑠𝑠𝑀𝑀𝑇𝑇𝑆𝑆 𝑇𝑇𝑇𝑇 𝑚𝑚𝑚𝑚
𝑆𝑆𝑇𝑇𝑀𝑀𝑇𝑇 𝑜𝑜𝑜𝑜 𝑅𝑅𝑇𝑇𝑅𝑅𝑀𝑀𝑇𝑇 𝑠𝑠𝑇𝑇𝑚𝑚𝑅𝑅𝑉𝑉𝑀𝑀 𝑇𝑇𝑇𝑇 𝑚𝑚𝑚𝑚2

























Example Calibration Data 
 
Table S3.2. 4F-MDMB-BINACA calibration curve data. 
Concentration Response IS Response Average Response Ratio Concentration Ratio 












































Figure S3.4. 4F-MDMB-BINACA calibration curve from 29/10/19. 
 
Table S3.3. 4F-MDMB-BINACA quality assurance data 






Calibration curve check standards 
196485 105292 1.87 0.80 32.19 µg/mL 32.54 µg/mL +1.07 
1150246 110959 10.37 2.21 93.85 µg/mL 92.18 µg/mL -1.78 
Batch SCRA spiked paper sample 












y = 1.7444x2 + 0.7935x + 0.1110 
R2 = 0.9994 
Table S3.4. Example 4F-MDMB-BINACA batch quantitation data.  










FL19/0077 313670 71416 4.39 1.36 109.13 0.94 ± 0.14 
FL19/0078-2 0 69191 <0.16 <0.13 <10.18 <0.09 ± 0.01 
FL19/0081 57441 62783 0.91 0.49 39.33 0.33 ± 0.05 
FL19/0082 281894 64073 4.40 1.36 109.24 0.90 ± 0.14 
FL19/0083 241088 68491 3.52 1.19 95.71 0.83 ± 0.13 
FL19/0119 29976 66388 0.45 0.27 21.70 0.19 ± 0.03 
FL19/0126 66435 63814 1.04 0.54 43.26 0.37 ± 0.06 
FL19/0129 96584 67650 1.43 0.67 53.99 0.47 ± 0.07 
FL19/0132-1 0 63337 <0.16 <0.13 <10.18 <0.09 ± 0.01 
FL19/0133-1 0 66109 <0.16 <0.13 <10.18 <0.09 ± 0.01 
FL19/0135-1 62014 66419 0.93 0.50 39.93 0.36 ± 0.05 
FL19/0135-3 5050 64561 <0.16 <0.13 <10.18 <0.09 ± 0.01 
FL19/0146 49574 68638 0.72 0.41 32.74 0.29 ± 0.04 
FL19/0151 39514 67049 0.59 0.34 27.65 0.24 ± 0.04 
FL19/0164-3 98224 64081 1.53 0.70 56.64 0.51 ± 0.08 
FL19/0180 16418 71040 <0.16 <0.13 <10.18 <0.09 ± 0.01 
FL19/0181-2 10857 64388 <0.16 <0.13 <10.18 <0.09 ± 0.01 
FL19/0183 22660 67766 0.33 0.20 15.83 0.14 ± 0.02 
FL19/0184 228078 66859 3.41 1.17 93.93 0.81 ± 0.12 
FL19/0185 117058 72951 1.60 0.73 58.40 0.52 ± 0.08 
 
Table S3.5. Quantitation method validation data: 4F-MDMB-BINACA spiked papers 
 
Sample Extractions Volume Response IS Response Response Ratio Concentration Ratio Concentration (µg/mL) Concentration (µg/cm2) % bias 
Mock 1 Quant 1 0.4754 547021 181021 3.02 1.86 147.36 70.00 -8.14 
Mock 2 Quant 1 0.4944 529416 177535 2.98 1.85 146.16 72.20 -5.25 
Mock 3 Quant 1 0.4654 559426 184730 3.03 1.86 147.56 68.62 -9.95 
Mock 4 Quant 1 0.5341 464751 167040 2.78 1.77 140.00 74.76 -1.89 
Mock 5 Quant 1 0.5401 446877 181100 2.47 1.64 129.87 70.13 -7.97 
Mock 6 Quant 1 0.5259 499954 173270 2.89 1.81 143.2 75.33 +1.15 
Mock 1 Quant 2 0.4754 498758 184251 2.71 1.74 137.63 65.37 -14.21 
Mock 2 Quant 2 0.4944 515625 169538 3.04 1.87 147.95 73.09 -4.08 
Mock 3 Quant 2 0.4654 557757 172617 3.23 1.94 153.58 71.42 -6.28 
Mock 4 Quant 2 0.5341 460152 162756 2.83 1.79 141.40 75.51 +0.91 
Mock 5 Quant 2 0.5401 457474 179634 2.55 1.67 132.47 71.53 -6.12 
Mock 6 Quant 2 0.5259 472585 173275 2.73 1.75 138.27 72.73 -4.55 
Mock 1 Quant 3 0.4754 503264 165992 3.03 1.86 147.67 70.14 -7.95 
Mock 2 Quant 3 0.4944 499954 168617 2.97 1.84 145.64 71.95 -5.58 
Mock 3 Quant 3 0.4654 542747 167067 3.25 1.95 154.09 71.65 -5.97 
Mock 4 Quant 3 0.5341 453218 161254 2.81 1.78 140.88 75.23 +1.27 
Mock 5 Quant 3 0.5401 430453 147758 2.91 1.82 144.06 77.79 +2.09 
Mock 6 Quant 3 0.5259 459411 165096 2.78 1.77 140.01 73.65 -3.35 
*There was an error with the extraction of one of the spiked samples because the glass vial used for extraction had chemical residue remaining from the glass washing processed used, which 














Table S3.6. Quantitation method validation data: 5F-MDMB-PINACA spiked papers 
 
Sample Extractions Volume Response IS Response Response Ratio Concentration Ratio Concentration (µg/mL) Concentration (µg/cm2) % bias 
Mock 1 Quant 1 0.5112 403021 120729 3.34 1.81 143.41 73.31 -4.55 
Mock 2 Quant 1 0.5623 335781 144061 2.33 1.47 116.32 65.40 -14.8 
Mock 3 Quant 1 0.5271 382317 126481 3.02 1.71 135.45 71.40 -7.03 
Mock 4 Quant 1 0.5307 392857 147556 2.66 1.59 125.81 66.77 -13.1 
Mock 5 Quant 1 0.5706 328676 137089 2.40 1.49 118.28 67.50 -12.1 
Mock 6 Quant 1 0.5409 361873 115708 3.13 1.74 138.14 74.71 -2.72 
Mock 1 Quant 2 0.5112 380711 138428 2.75 1.62 128.22 65.54 -14.7 
Mock 2 Quant 2 0.5623 360432 137415 2.62 1.57 124.72 70.13 -8.69 
Mock 3 Quant 2 0.5271 391140 136648 2.86 1.66 131.24 69.18 -9.92 
Mock 4 Quant 2 0.5307 400168 140578 2.85 1.65 130.82 69.43 -9.59 
Mock 5 Quant 2 0.5706 341613 139421 2.45 1.51 119.82 68.37 -11.0 
Mock 6 Quant 2 0.5409 349628 128349 2.72 1.61 127.51 68.96 -10.2 
Mock 1 Quant 3 0.5112 394140 131869 2.99 1.70 134.57 68.79 -10.4 
Mock 2 Quant 3 0.5623 361310 109071 3.31 1.80 142.78 80.28 +4.53 
Mock 3 Quant 3 0.5271 385529 140884 2.74 1.61 127.85 67.39 -12.3 
Mock 4 Quant 3 0.5307 397447 131533 3.02 1.71 135.42 71.87 -6.41 
Mock 5 Quant 3 0.5706 337505 139064 2.43 1.50 119.14 67.99 -11.5 
Mock 6 Quant 3 0.5409 372661 131374 2.84 1.65 130.55 70.61 -8.06 
*There was an error with one of the spiked samples, which was clear from the significantly low SCRA responses in all three replicates of the sample extraction. In addition, the same error in 
the spiked sample was seen in those samples with AMB-FUBINACA. Since there was one 1 mg/mL solution for 5F-MDMB-PINACA and AMB-FUBINACA combined, the consistency in 
the low concentration of SCRAs in this sample provides confidence that there was an error with the infusion of the spiked paper or the extraction of that sample. For that reason, those 













Table S3.7. Quantitation method validation data: AMB-FUBINACA 
 
Sample Extractions Volume Response IS Response Response Ratio Concentration Ratio Concentration (µg/mL) Concentration (µg/cm2) % bias 
Mock 1 Quant 1 0.5112 513529 120729 4.25 1.94 153.37 78.40 +4.11 
Mock 2 Quant 1 0.5623 427255 144061 2.97 1.54 121.76 68.47 -9.08 
Mock 3 Quant 1 0.5271 501451 126481 3.96 1.85 146.74 77.36 +2.73 
Mock 4 Quant 1 0.5307 501659 147556 3.40 1.68 133.06 70.62 -6.21 
Mock 5 Quant 1 0.5706 433039 137089 3.16 1.60 126.88 72.41 -3.84 
Mock 6 Quant 1 0.5409 480202 115708 4.15 1.91 151.02 81.68 +8.48 
Mock 1 Quant 2 0.5112 506673 138428 3.66 1.76 139.50 71.31 -5.30 
Mock 2 Quant 2 0.5623 475371 137415 3.46 1.70 134.56 75.66 +0.48 
Mock 3 Quant 2 0.5271 513971 136648 3.76 1.79 141.94 74.82 -0.64 
Mock 4 Quant 2 0.5307 536327 140578 3.82 1.81 143.22 76.01 +0.95 
Mock 5 Quant 2 0.5706 455589 139421 3.27 1.64 129.70 74.01 -1.71 
Mock 6 Quant 2 0.5409 465099 128349 3.62 1.75 138.61 74.97 -0.44 
Mock 1 Quant 3 0.5112 521026 131869 3.95 1.85 146.43 74.85 -0.60 
Mock 3 Quant 3 0.5271 511705 140884 3.63 1.75 138.82 73.18 -2.82 
Mock 4 Quant 3 0.5307 534080 131533 4.06 1.88 148.97 79.06 +5.00 
Mock 5 Quant 3 0.5706 452291 139064 3.25 1.63 129.31 73.79 -2.01 
Mock 6 Quant 3 0.5409 510582 131374 3.89 1.83 144.91 78.38 +4.09 
*There was an error with one of the spiked samples, which was clear from the significantly low SCRA responses in all three replicates of the sample extraction. In addition, the same error in 
the spiked sample was seen in those samples with 5F-MDMB-PINACA. Since there was one 1 mg/mL solution for AMB-FUBINACA and 5F-MDMB-PINACA combined, the consistency 
in the low concentration of SCRAs in this sample provides confidence that there was an error with the infusion of the spiked paper or the extraction of that sample. For that reason, those 
sample quantitations were removed from this dataset.  
**There was an error in the two-fold dilution with the third quantitation sample of the second spiked paper (Mock 2) that resulted in abnormally low internal standard concentration, leading 












Table S3.8. Quantitation method validation data: 5F-MDMB-PICA spiked papers 
 
Sample Extractions Volume Response IS Response Response Ratio Concentration Ratio Concentration (µg/mL) Concentration (µg/cm2) % bias 
Mock 1 Quant 1 0.5261 273797 101753 2.69 1.81 143.35 75.41 +1.36 
Mock 2 Quant 1 0.5353 288632 124669 2.32 1.65 131.02 70.13 -5.74 
Mock 3 Quant 1 0.5543 271490 110996 2.45 1.71 135.42 75.07 +0.89 
Mock 4 Quant 1 0.5757 247955 121982 2.03 1.53 121.08 69.71 -6.30 
Mock 5 Quant 1 0.5158 268730 125702 2.14 1.58 124.85 64.40 -13.5 
Mock 1 Quant 2 0.5261 295037 139197 2.12 1.57 124.20 65.34 -12.2 
Mock 2 Quant 2 0.5353 286167 149330 1.92 1.47 116.79 62.51 -16.0 
Mock 3 Quant 2 0.5543 283231 139217 2.03 1.53 121.15 67.15 -9.74 
Mock 4 Quant 2 0.5757 263728 135132 1.95 1.49 118.11 68.00 -8.60 
Mock 5 Quant 2 0.5158 278020 123184 2.26 1.63 129.02 66.54 -10.6 
Mock 1 Quant 3 0.5261 295270 143929 2.05 1.54 121.76 64.05 -13.9 
Mock 2 Quant 3 0.5353 299923 144158 2.08 1.55 122.81 65.73 -11.7 
Mock 3 Quant 3 0.5543 352296 163205 2.16 1.59 125.59 69.62 -6.43 
Mock 4 Quant 3 0.5757 258767 134187 1.93 1.48 117.24 67.50 -9.27 
Mock 5 Quant 3 0.5158 272206 112288 2.42 1.70 134.69 69.47 -6.63 
*There was an error with two of the spiked samples, which was clear from the significantly low response ratios in all three replicates of the sample extraction. In addition, the same error in 
the spiked sample was seen in those samples with AMB-CHMICA. Since there was one 1 mg/mL solution for 5F-MDMB-PICA and AMB-CHMICA combined, the consistency in the low 
concentration of SCRAs in this sample provides confidence that there was an error with the infusion of the spiked paper or the extraction of that sample. For that reason, those sample 















Table S3.9. Quantitation method validation data: AMB-CHMICA spiked papers 
 
Sample Extractions Volume Response IS Response Response Ratio Concentration Ratio Concentration (µg/mL) Concentration (µg/cm2) % bias 
Mock 1 Quant 1 0.5261 361764 101753 3.56 1.98 160.64 84.51 +11.3 
Mock 2 Quant 1 0.5353 383912 124669 3.08 1.81 147.25 78.82 +3.84 
Mock 3 Quant 1 0.5543 368311 110996 3.32 1.90 154.08 85.41 +12.5 
Mock 4 Quant 1 0.5757 332465 121982 2.73 1.68 136.65 78.67 +3.66 
Mock 5 Quant 1 0.5158 357237 125702 2.84 1.73 140.20 72.31 -4.73 
Mock 1 Quant 2 0.5261 390985 139197 2.81 1.72 139.20 73.23 -3.52 
Mock 2 Quant 2 0.5353 378113 149330 2.53 1.61 130.58 69.89 -7.91 
Mock 3 Quant 2 0.5543 378921 139217 2.72 1.68 136.53 75.69 +0.28 
Mock 4 Quant 2 0.5757 346660 135132 2.57 1.62 131.64 75.79 +0.14 
Mock 5 Quant 2 0.5158 369579 123184 3.00 1.79 144.93 74.75 -1.51 
Mock 1 Quant 3 0.5261 393031 143929 2.73 1.69 136.81 71.97 -5.18 
Mock 2 Quant 3 0.5353 408121 144158 2.83 1.72 139.88 74.87 +1.36 
Mock 3 Quant 3 0.5543 452074 163205 2.77 1.70 138.02 76.51 +0.80 
Mock 4 Quant 3 0.5757 343294 134187 2.56 1.62 131.42 75.66  +0.31 
Mock 5 Quant 3 0.5158 358040 112288 3.19 1.85 150.41 77.57 +2.21 
*There was an error with two of the spiked samples, which was clear from the significantly low response ratios in all three replicates of the sample extraction. In addition, the same error in 
the spiked sample was seen in those samples with 5F-MDMB-PICA. Since there was one 1 mg/mL solution for AMB-CHMICA and 5F-MDMB-PICA combined, the consistency in the low 
concentration of SCRAs in this sample provides confidence that there was an error with the infusion of the spiked paper or the extraction of that sample. For that reason, those sample 















Table S3.10. Quantitation method validation data: Statistical analysis overview. 
 
SCRA p-value Sample Mean Minimum Maximum SEM 
4F-MDMB-BINACA 0.54 
Mock 1 68.50 65.37 70.14 1.57 
Mock 2 72.41 71.95 73.09 0.35 
Mock 4 70.56 68.62 71.65 0.97 
Mock 5 75.17 74.76 75.51 0.22 
Mock 6 73.15 70.13 77.79 2.35 
Mock 7 73.90 72.73 75.33 0.76 
Total 72.28 65.37 77.79 0.69 
5F-MDMB-PICA 0.07 
Mock 1 68.27 64.05 75.41 3.59 
Mock 2 66.13 62.51 70.13 2.21 
Mock 3 70.61 67.15 75.07 2.34 
Mock 6 68.40 67.50 69.71 0.67 
Mock 7 66.80 64.40 69.47 1.47 
Total 68.04 62.51 75.41 0.95 
AMB-CHMICA 0.05 
Mock 1 76.57 71.97 84.51 3.99 
Mock 2 74.53 69.89 78.82 2.58 
Mock 3 79.20 75.69 85.41 3.12 
Mock 6 76.71 75.66 78.67 0.98 
Mock 7 74.88 72.31 77.57 1.52 
Total 76.38 69.89 85.41 1.10 
AMB-FUBINACA 0.16 
Mock 1 74.85 71.31 78.40 2.05 
Mock 3 72.06 68.47 75.66 3.60 
Mock 4 75.12 73.18 77.36 1.22 
Mock 5 75.23 70.62 79.06 2.47 
Mock 6 73.40 72.41 74.01 0.50 
Mock 7 78.34 74.97 81.68 1.94 
Total 75.00 68.47 81.68 0.81 
5F-MDMB-PINACA 0.50 
Mock 1 69.21 65.54 73.31 2.25 
Mock 3 71.94 65.40 80.28 4.39 
Mock 4 69.33 67.39 71.40 1.16 
Mock 5 69.36 66.77 71.87 1.47 
Mock 6 67.95 67.50 68.37 0.25 
Mock 7 71.43 68.96 74.71 1.71 
Total 69.87 65.40 80.28 0.87 
*The p-value is from the single factor ANOVA comparing the three consecutive sets of the spiked paper samples run for each SCRA, where the alpha value was 0.05. 
SECTION 4 
 
SCRA market evolution across three Scottish Prisons 





Figure S4.1. Timeline of the total synthetic cannabinoid receptor agonist concentrations of all quantitated samples with a seizure date from three Scottish 
prisons (n=137) where error bars represent the 15% error determined from the series of spiked samples run for method validation. Any samples on the x-axis 




Contextual information and analytical data for infused paper samples seized in 3 Scottish 
prisons and found to contain synthetic cannabinoid receptor agonists (SCRAs) 
 

























1 01/06/18 FL19/0002-2 5F-MDMB-PINACA 9.36 935 377 0.16 303 378.2190 378.2193 -0.8 346.1941, 318.1986, 233.1101(base peak), 177.0472, 145.0404 
1 08/06/19 FL19/0003-1 
AMB-FUBINACA 10.02 945 383 NA 302 384.1725 384.1723 0.5 352.1480, 324.1527, 281.1523, 253.0800(base peak), 225.0850 
EMB-FUBINACA 10.15 862 397 NA 301 398.1890 398.1880 2.5 352.1482, 324.15067, 253.0782(base peak), 225.0847, 109.0451 
4F-PHP 7.25 934 263 NA NA 264.1765 264.1764 0.4 193.1042, 140.1448, 123.0250, 109.0454 
1 12/06/18 FL19/0004-2 5F-MDMB-PINACA 9.42 940 377 NA 303 378.2192 378.2193 -0.3 346.1937, 318.1995, 233.1104(base peak), 177.0482, 145.0413 
1 21/06/18 
FL19/0006-1 5F-MDMB-PINACA 9.36 924 377 0.22 303 378.2195 378.2193 -0.5 346.1950, 318.2008, 233.1115(base peak), 177.0482, 145.0417 




AMB FUBINACA 10.00 941 383 1.05 303 384.1719 384.1723 -1.0 352.1446, 324.1527, 281.1558, 253.0797(base peak), 225.0854 
EMB-FUBINACA 10.23 903 397 NA 301 398.1890 398.1880 2.5 352.1465, 324.1503, 253.0779(base peak), 225.0847, 109.0455 
FL19/0007-2 5F-MDMB-PINACA 9.45 932 377 0.19 303 378.2209 378.2193 4.2 346.1923, 318.1992, 233.1109(base peak), 145.0421, 121.0479 
1 15/07/18 FL19/0012-3 5F-MDMB-PINACA 9.49 931 377 0.44 303 378.2202 378.2193 2.4 346.1936, 318.2013, 233.1120(base peak), 177.0493, 145.0424 
1 06/08/18 FL19/0013-1 5F-MDMB-PINACA 9.42 933 377 0.16 303 378.2193 378.2193 0.0 346.1949, 318.1999, 233.1109(base peak), 177.0475, 145.0409 
1 07/08/18 FL19/0014 5F-MDMB-PINACA 9.41 940 377 0.52 303 378.2201 378.2193 2.1 346.1932, 318.1985, 233.1100(base peak), 177.0474, 145.0413 
1 30/09/18 FL19/0020 5F-MDMB-PINACA 9.36 935 377 0.08 303 378.2194 378.2193 0.3 346.1938, 318.1990, 233.1103(base peak), 177.0473, 145.0407 
1 16/09/18 
FL19/0022-4 5F-MDMB-PINACA 9.32 937 377 0.59 303 378.2203 378.2193 2.7 346.1938, 318.1990, 233.1103(base peak), 177.0473, 145.0408 
FL19/0022-5 5F-MDMB-PINACA 9.34 930 377 0.49 303 378.2186 378.2193 -1.8 346.1938, 318.1990, 233.1103(base peak), 177.0473, 145.0409 
1 14/10/18 FL19/0023-2 5F-MDMB-PINACA 9.38 927 377 0.19 303 378.2193 378.2193 0.0 346.1929, 317.1983, 233.1105(base peak), 177.0490, 145.0426 
1 15/10/18 FL19/0024 5F-MDMB-PINACA 9.37 937 377 0.17 303 378.2190 378.2193 -0.8 346.1939, 318.1985, 233.1103(base peak), 145.0399 
1 18/10/18 FL19/0025-1 5F-MDMB-PINACA 9.47 931 377 0.34 303 378.2198 378.2193 1.3 346.1922, 318.2207, 233.1107(base peak), 177.0473, 145.0402 
1 18/10/18 FL19/0027-1 5F-MDMB-PINACA 9.38 927 377 0.37 303 378.2206 378.2193 3.4 346.1945, 318.1996, 233.1112(base peak), 177.0481, 145.0421 
1 12/11/18 FL19/0034 5F-MDMB-PINACA 9.35 919 377 0.47 303 378.2196 378.2193 0.8 346.1960, 318.1999, 233.1113(base peak), 177.0483, 145.0423 
1 02/12/18 FL19/0039 5F-MDMB-PINACA 9.44 934 377 0.79 303 378.2197 378.2193 1.1 346.1929, 318.2005, 233.1120(base peak), 177.0490, 145.0429 
1 02/12/18 FL19/0040 5F-MDMB-PINACA 9.38 939 377 0.14 303 378.2198 378.2193 1.3 346.1950, 318.1994, 233.1103(base peak), 145.0396 
1 06/01/19 FL19/0043 5F-MDMB-PINACA 9.38 934 377 0.88 303 378.2201 378.2193 2.1 346.1960, 318.2005, 233.1111(base peak), 177.0485, 145.0417 
1 26/01/19 FL19/0052-2 5F-MDMB-PICA 10.17 927 376 NA 292 377.2250 377.224 2.7 232.1152 (base peak), 144.0462 
1 02/02/19 FL19/0057-2 5F-MDMB-PICA 10.13 931 376 NA 292 377.2249 377.224 2.4 232.1146 (base peak), 144.0448 
1 29/01/19 FL19/0059-1 5F-MDMB-PINACA 9.52 933 377 1.17 303 378.2199 378.2193 1.6 346.1915, 318.2001, 233.1121(base peak), 177.0497, 145.0431 
1 08/02/19 FL19/0060 5F-MDMB-PICA 10.16 929 376 0.20 292 377.2257 377.224 4.5 232.1153 (base peak), 144.0461 
1 13/02/19 FL19/0061-1 5F-MDMB-PICA 10.24 929 376 0.76 292 377.2266 377.224 6.9 232.1151 (base peak), 144.0461 

























1 NA FL19/0064 5F-MDMB-PICA 10.15 930 376 0.30 292 377.2253 377.224 3.4 232.1155 (base peak), 144.0461 
1 N/A 
FL19/0066-4 5F-MDMB-PICA 10.24 927 376 0.62 292 377.2249 377.224 2.4 232.1145 (base peak), 144.0450 
FL19/0066-5 5F-MDMB-PICA 10.23 932 376 0.61 292 377.2253 377.224 3.4 232.1160 (base peak), 144.0464 
FL19/0066-8 5F-MDMB-PICA 10.21 931 376 0.73 292 377.2261 377.224 5.6 232.1155 (base peak), 144.0464 
FL19/0066-9 5F-MDMB-PICA 10.19 934 376 0.44 292 377.2270 377.224 8.0 232.1148 (base peak), 144.0455 
1 23/11/18  FL19/0067-2 
CUMYL-4CN-BINACA 11.42 897 361 NA 303 361.2027 361.2028 -0.3 243.1261, 226.0999(base peak), 145.0421, 119.0879 
5F-MDMB-PICA 10.13 784 376 NA 292 377.2234 377.224 -1.6 232.1145 (base peak), 144.0478 
AMB-FUBINACA 9.95 934 383 NA 303 384.1717 384.1723 -1.6 352.1475, 324.1536, 281.1567, 253.0800(base peak), 225.0854 
5F-MDMB-PINACA 9.44 933 377 0.07 303 378.2206 378.2193 3.5 346.1932, 318.2001, 233.1120(base peak), 177.0491, 145.0432 
1 23/11/18 FL19/0067-1 5F-MDMB-PINACA 9.44 938 377 0.12 303 378.2200 378.2193 1.9 346.1931, 318.1997, 233.1102(base peak), 145.0410 
1 N/A 
FL19/0070-1 5F-MDMB-PINACA 9.37 932 377 0.24 303 378.2196 378.2193 0.8 346.1953, 318.1993, 233.1117(base peak), 177.0488, 145.0424 
FL19/0070-2 5F-MDMB-PINACA 9.34 923 377 0.05 303 378.2195 378.2193 0.5 346.1946, 318.1996, 233.1107(base peak), 177.0477, 145.0409 
1 18/06/18 FL19/0071 5F-MDMB-PINACA 9.35 918 377 0.40 303 378.2195 378.2193 0.5 346.1942, 318.1989, 233.1108(base peak), 177.0477, 145.0420 
1 11/01/19 
FL19/0072-1 5F-MDMB-PINACA 9.36 911 377 0.20 303 378.2184 378.2193 -2.4 346.2447, 318.2460, 233.1444(base peak), 177.0735, 145.0623 
FL19/0072-2 5F-MDMB-PICA 10.06 913 376 0.16 292 377.2227 377.224 -3.4 232.1142 (base peak), 144.0452 
FL19/0072-3 5F-MDMB-PINACA 9.38 941 377 0.30 303 378.2193 378.2193 0.0 346.1943, 318.1985, 233.1104(base peak), 177.0473, 145.0407 
1 13/02/19 FL19/0074-2 5F-MDMB-PICA 10.20 931 376 NA 292 377.2259 377.224 5.0 232.1159 (base peak), 144.0473 
1 08/07/19 FL19/0075-3 5F-MDMB-PINACA 9.48 933 377 1.05 303 378.2189 378.2193 -1.1 346.1918, 318.2005, 233.1112(base peak), 177.0485, 145.0421 
2 N/A 
FL19/0077-1 4F-MDMB-BINACA 9.27 931 363 NA 303 364.2014 364.2043 -8.0 332.1737, 304.1848, 219.0951(base peak), 177.0489, 145.0417 
FL19/0077-2 4F-MDMB-BINACA 9.13 911 363 0.94 303 364.2041 364.2043 -0.5 332.1737, 304.1848, 219.0951(base peak), 177.0489, 145.0417 
2 11/02/19 FL19/0078-2 4F-MDMB-BINACA 9.11 948 363 <0.09 303 364.2039 364.2043 -1.1 332.1769, 304.1818, 219.0945(base peak), 177.0477, 145.0407 
2 11/02/19 FL19/0079 5F-MDMB-PICA 10.17 933 376 0.37 291 377.2249 377.224 2.4 232.1155 (base peak), 144.0470 
2 18/03/19 FL19/0081 4F-MDMB-BINACA 9.10 920 364 0.33 302 364.2034 364.2043 -2.5 332.1787, 304.1846, 219.0955(base peak), 177.0486, 145.0424 
2 24/03/19 FL19/0082 4F-MDMB-BINACA 9.11 932 364 0.90 303 364.2036 364.2043 1.9 332.1759, 304.2268, 219.1258(base peak), 177.0737, 145.0627 
2 26/03/19 FL19/0083 4F-MDMB-BINACA 9.20 933 364 0.83 303 364.2043 364.2043 0.0 332.1745, 304.1852, 219.0952(base peak), 177.0492, 145.0424 
1 25/02/19 
FL19/0091-2 5F-MDMB-PINACA 9.34 924 377 0.77 303 378.2206 378.2193 3.4 346.1928, 318.2007, 233.1116(base peak), 177.0486, 145.0425 
FL19/0091-3 5F-MDMB-PINACA 9.34 921 377 0.89 303 378.2203 378.2193 2.6 346.1931, 318.1996, 233.1100(base peak), 177.0467, 145.0408 
FL19/0091-4 5F-MDMB-PINACA 9.35 927 377 0.73 303 378.2207 378.2193 3.7 346.1926, 318.2004, 233.1107(base peak), 177.0481, 145.0415 
1 01/03/19 
FL19/0095-1 5F-MDMB-PINACA 9.39 929 377 0.40 303 378.2207 378.2193 3.7 346.1931, 318.1993, 233.1110(base peak), 177.0479, 145.0420 
FL19/0095-2 5F-MDMB-PINACA 9.33 919 377 NA 303 378.2200 378.2193 1.9 346.1944, 318.1989, 233.1102(base peak), 177.0463, 145.0396 

























1 05/03/19 FL19/0096-2 5F-MDMB-PICA 9.71 899 376 0.08 292 377.2244 377.224 1.1 377.2206, 232.1147 (base peak), 144.0447 
1 05/03/19 FL19/0097 AMB-CHMICA 10.83 899 370 0.58 292 371.2346 371.2334 3.2 371.2173, 240.1396 (base peak), 144.0453 
1 07/03/19 FL19/0100 5F-MDMB-PICA 10.03 913 376 0.45 292 377.2246 377.224 1.6 377.2091, 232.1151(base peak), 144.0470 
1 07/03/19 FL19/0102-2 5F-MDMB-PICA 9.98 899 376 0.16* 292 377.2244 377.224 1.1 377.2183, 232.1146(base peak), 144.0444 
1 08/03/19 FL19/0104 5F-MDMB-PINACA 9.36 928 377 0.93 303 378.2210 378.2193 4.5 346.1941, 318.2016, 233.1127(base peak), 177.0495, 145.0433 
1 14/03/19 
FL19/0105-3A 5F-MDMB-PICA 9.82 932 376 0.42 291 377.2257 377.224 4.5 232.1164 (base peak), 144.0471 
FL19/0105-3D 5F-MDMB-PICA 9.82 932 376 0.47 291 377.2258 377.224 4.8 232.1153 (base peak), 144.0463 
FL19/0105-3G 5F-MDMB-PICA 9.82 932 376 0.37 291 377.2249 377.224 2.4 232.1151 (base peak), 144.0453 
FL19/0105-3I 5F-MDMB-PICA 9.82 932 376 NA 291 377.2242 377.224 0.5 232.1146 (base peak), 144.0461 
FL19/0105-3J 5F-MDMB-PICA 9.82 932 376 0.32 291 377.2244 377.224 1.1 232.1155 (base peak), 144.0479 
1 24/03/19 
FL19/0107-1 5F-MDMB-PICA 9.99 919 376 0.30 292 377.2239 377.224 -0.3 377.2131, 232.1146(base peak), 144.0426 





5F-MDMB-PINACA 9.34 931 377 0.13 303 378.2185 378.2193 -2.1 346.1942, 318.1991, 233.1103(base peak), 177.0472, 145.0406 




5F-MDMB-PINACA 9.31 916 377 0.12 303 378.2196 378.2193 0.8 346.1943, 318.1988, 233.1096(base peak), 177.0460, 145.0399 
5F-MDMB-PICA 9.99 911 376 0.22 292 377.2246 377.224 1.6 377.2249, 232.1153(base peak), 144.0481 
FL19/0111-6 
AMB-FUBINACA 9.90 947 383 1.16 302 384.1724 384.1723 0.3 352.1463, 342.1522, 253.0796 (base peak), 109.0463 
EMB-FUBINACA 10.02 900 397 NA 301 398.1889 398.1880 2.3 352.1484, 324.1511, 253.0790(base peak), 225.0820, 109.0456 
4F-PHP 7.20 924 263 NA NA 264.1772 264.1764 3.0 193.1051, 140.1460, 123.0262, 109.0469 
FL19/0111-7 5F-MDMB-PINACA 9.31 919 377 0.12 303 378.2192 378.2193 -0.3 346.1942, 318.1995, 233.1105(base peak), 177.0471, 145.0405 
1 NA 
FL19/0115-3 5F-MDMB-PICA 10.04 915 376 0.36 292 377.2249 377.224 2.4 377.2094, 232.1150 (base peak), 144.0461 
FL19/0115-4 5F-MDMB-PICA 10.01 915 376 0.27 292 377.2246 377.224 1.6 377.2107, 232.1145 (base peak), 144.0464 
FL19/0115-5 5F-MDMB-PINACA 9.35 930 377 0.19 303 378.2207 378.2193 3.7 346.1928, 318.1992, 233.1108(base peak), 177.0480, 145.0409 
FL19/0115-7 5F-MDMB-PICA 9.98 905 376 0.29 292 377.2239 377.224 -0.3 377.2131, 232.1138 (base peak), 144.0445 
FL19/0115-8 5F-MDMB-PICA 10.01 904 376 0.67 292 377.2239 377.224 -0.3 377.2107, 232.1140 (base peak), 144.0454 
1 NA FL19/0116 5F-MDMB-PINACA 9.28 882 377 <0.05 303 378.2176 378.2193 -4.5 346.1941, 318.1982, 233.1096(base peak), 177.0482, 145.0415 
3 15/05/19 FL19/0119 4F-MDMB-BINACA 9.40 938 363 0.19 302 364.2038 364.2043 -1.4 332.1770, 304.1849, 219.0952(base peak), 177.0485, 145.0416 
3 17/05/19 FL19/0120 5F-MDMB-PICA 10.39 906 376 0.55 292 377.2242 377.224 0.5 232.1141 (base peak), 144.0457 
3 17/05/19 FL19/0123 5F-MDMB-PINACA 9.63 934 377 <0.05 302 378.2192 378.2193 -0.3 346.1945, 318.1990, 233.1111(base peak), 177.0477, 145.0416 
3 03/06/19 FL19/0126 4F-MDMB-BINACA 9.36 923 363 0.37 303 364.2042 364.2043 -0.3 332.1763, 304.1846, 219.0958(base peak), 177.0493, 145.0427 
































4F-MDMB-BINACA 9.27 907 363 NA 303 364.2032 364.2043 -3.0 332.1782, 304.1840, 219.0947(base peak), 177.0469, 145.0422 
MDMB-FUBINACA 10.23 803 397 NA ND ND ND ND ND 
 MMB-CHMICA 11.23 849 371 NA ND ND ND ND ND 
3 07/06/19 FL19/0129 4F-MDMB-BINACA 9.38 872 363 0.47 303 364.2033 364.2043 -2.7 332.1753, 304.1844, 219.0948(base peak), 177.0486, 145.0409 
3 11/06/19 FL19/0131 5F-MDMB-PICA 9.22 883 376 0.66 292 377.2252 377.224 3.2 232.1141 (base peak), 144.0455 
3 18/06/19 FL19/0132-1 4F-MDMB-BINACA 9.29 942 363 <0.09 303 364.2033 364.2043 -2.7 332.1759, 304.2268, 219.1258(base peak), 177.0737, 145.0627 
3 18/06/19 FL19/0133-1 4F-MDMB-BINACA 9.28 852 363 <0.09 303 364.2022 364.2043 -5.8 332.1765, 304.1813, 219.0932(base peak), 177.0468, 145.0401 
3 21/06/19 
FL19/0135-1 4F-MDMB-BINACA 9.32 919 363 0.36 303 364.2027 364.2043 -4.4 332.2277, 304.2282, 219.1266(base peak), 177.0743, 145.0629 
FL19/0135-2 5F-MDMB-PICA 10.44 925 376 0.69 292 377.2251 377.224 2.9 232.1137 (base peak), 144.0446 
FL19/0135-3 4F-MDMB-BINACA 9.29 942 363 <0.09 303 364.2029 364.2043 -3.8 332.1779, 304.1830, 219.0942(base peak), 177.0477, 145.0404 
3 21/06/19 FL19/0136 5F-MDMB-PICA 10.44 923 376 0.20 292 377.2251 377.224 2.9 232.1157 (base peak), 144.0473 
3 25/06/19 FL19/0138-1 5F-MDMB-PICA 10.39 922 376 0.21 292 377.2242 377.224 0.5 232.1490 (base peak), 144.0676 
3 21/05/19 FL19/0141 5F-MDMB-PICA 9.72 930 376 0.16 292 377.2253 377.224 3.4 232.1142 (base peak), 144.0457 
3 17/06/19 FL19/0142-1 
MDMB-4en-PINACA 8.84 938 357 0.38 302 358.2132 358.2131 0.3 326.1877, 298.1921, 213.1033(base peak), 171.0581, 145.0404 
4F-MDMB-BINACA 8.94 702 363 0.11 303 364.2027 364.2018 2.5 332.1783, 304.1830, 219.0950(base peak), 177.0485, 145.0415 
3 20/06/19 
FL19/0143-5 5F-MDMB-PICA 9.75 923 376 0.27 292 377.2254 377.224 3.7 232.1150 (base peak), 144.0470 
FL19/0143-8 5F-MDMB-PICA 9.71 932 376 NA 292 377.2251 377.224 2.9 232.1189 (base peak), 144.0676 
3 24/04/19 FL19/0145-1 5F-MDMB-PICA 9.81 929 376 0.64 NA NA NA NA NA 
3 04/05/19 FL19/0146 
4F-MDMB-BINACA 8.94 936 363 0.29 303 364.2018 364.2043 -6.9 332.1743, 304.1847, 219.0946(base peak), 177.0487, 145.0413 
5F-MDMB-PICA 9.85 928 376 NA 292 377.2250 377.224 2.7 232.1143 (base peak), 144.0455 
3 06/03/19 FL19/0148-1 5F-MDMB-PICA 9.68 934 376 NA 292 377.2254 377.224 3.7 232.1153 (base peak), 144.0466 
3 17/08/18 FL19/0149 
AMB-FUBINACA 9.60 940 383 0.20 302 384.1740 384.1723 4.4 352.1474, 342.152217, 253.0798 (base peak), 109.0464 
4F-PHP 7.05 957 263 NA NA 264.1772 264.1764 1.9 193.1015, 140.1449, 123.0253, 109.0460 
3 09/06/19 FL19/0150 
MDMB-4en-PINACA 8.86 948 357 0.25 303 358.2130 358.2131 -0.3 326.1844, 298.1916, 213.1048(base peak), 171.0602, 145.0427 
4F-MDMB-BINACA 8.88 894 363 0.15 303 364.2042 364.2043 -0.3 332.1738, 304.1835, 219.0948(base peak), 177.0482, 145.0422 
3 26/04/19 FL19/0151 4F-MDMB-BINACA 8.88 928 363 0.24 303 364.2039 364.2043 -1.1 332.2257, 304.2274, 219.1268(base peak), 177.0740, 145.0626 
3 08/11/18 FL19/0157-1 5F-MDMB-PINACA 9.20 932 377 0.65 303 378.2188 378.2193 -1.3 346.1932, 318.2004, 233.1112(base peak), 177.0481, 145.0421 
3 NA FL19/0158 5F-MDMB-PICA 9.70 932 376 <0.09 292 377.2249 377.224 2.4 232.1489 (base peak), 144.00679 
3 17/04/19 
FL19/0164-1` 5F-MDMB-PICA 9.76 932 376 0.31 292 377.2264 377.224 6.4 232.1154 (base peak), 144.0470 
FL19/0164-2 5F-MDMB-PICA 9.79 926 376 0.52 292 377.2260 377.224 5.3 232.1149 (base peak), 144.0462 


























FL19/0164-3 4F-MDMB-BINACA 8.94 941 363 0.51 303 364.2038 364.2043 -1.4 332.1740, 304.1846, 219.0947(base peak), 177.0493, 145.0421 
FL19/0164-4 5F-MDMB-PICA 9.77 926 376 0.70 292 377.2264 377.224 6.4 232.1150 (base peak), 144.0467 
1 05/07/19 FL19/0178-3 
AMB-FUBINACA 9.58 941 383 NA 301 384.1720 378.2193 0.8 352.1441, 225.0854, 253.0797(base peak), 334.1526, 109.0471 
EMB-FUBINACA 9.68 898 397 NA NA NA NA NA NA 
1 01/07/19 FL19/0180 4F-MDMB-BINACA 8.80 938 363 NA 303 364.2033 364.2043 2.7 332.1776, 304.1829, 219.0947(base peak), 177.0482, 145.0430 
1 09/07/19 
FL19/0181-1 5F-MDMB-PICA 9.66 919 376 0.75 291 377.2238 377.2240 0.5 232.1147(base peak), 144.0461 
FL19/0181-2 4F-MDMB-BINACA 8.79 940 363 <0.09 303 364.2032 364.2043 3.0 332.1776, 304.1829, 219.0947(base peak), 177.0482, 145.0430 
FL19/0181-3 
MDMB-4en-PINACA 8.77 927 357 NA 303 358.2129 358.2131 0.6 326.1866, 298.1914, 213.1040(base peak), 171.0585, 145.0410 
5F-MDMB-PICA 9.63 918 376 0.22 302 377.2245 377.2240 -1.3 232.1150(base peak), 144.0467 
1 16/07/19 FL19/0183 4F-MDMB-BINACA 8.81 942 363 0.14 303 364.2034 364.2043 2.5 332.1758, 304.1835, 219.0949(base peak), 177.0455, 145.0411 
1 16/07/19 FL19/0184 4F-MDMB-BINACA 8.80 945 363 0.81 303 364.2029 364.2043 3.8 332.1736, 304.1836, 219.0947(base peak), 177.0488, 145.0417 
1 16/07/19 FL19/0185 4F-MDMB-BINACA 8.81 940 363 0.52 303 364.2032 364.2043 3.0 332.1760, 304.1838, 219.0956(base peak), 177.0495, 145.0430 
1 16/07/19 FL19/0186 4F-MDMB-BINACA 8.82 937 363 0.37 303 264.2032 364.2043 3.0 332.1787, 304.1841, 219.0950(base peak), 177.0485, 145.0419 
1 NA FL19/0188 5F-MDMB-PICA 9.69 916 376 0.52 292 377.2237 377.2240 0.8 232.1156(base peak), 144.0466 
1 31/07/19 
FL19/0189-1 5F-MDMB-PICA 9.67 914 376 0.49 292 377.2240 377.2240 0.0 232.1156(base peak), 144.0467 
FL19/0189-2 5F-MDMB-PICA 9.65 917 376 0.35 292 377.2241 377.2240 -0.3 232.1152(base peak), 144.0466 
1 25/06/19 FL19/0190 4F-MDMB-BINACA 8.82 940 363 0.44 303 364.2031 364.2043 4.7 332.1749, 304.1834, 219.0954(base peak), 177.0484, 145.0422 
1 16/07/19 FL19/0191 4F-MDMB-BINACA 8.82 941 363 0.55 303 364.2031 364.2043 3.3 332.1754, 304.1837, 219.0956(base peak), 177.0487, 145.0424 
1 N/A FL19/0194 5F-MDMB-PICA 9.67 925 376 0.21 292 377.2240 377.2240 0.0 232.1146(base peak), 144.0450 
1 N/A FL19/0196 
4F-MDMB-BINACA 8.81 931 363 0.24 303 364.2029 364.2043 3.8 332.1743, 304.1840, 219.0962(base peak), 177.0494, 145.0427 
MDMB-4en-PINACA 8.79 941 357 0.15 303 358.2123 358.2131 2.2 326.1847, 298.1933, 213.1040(base peak), 171.0607, 145.0424 
1 29/08/19 FL19/0197-2 4F-MDMB-BINACA 8.81 941 363 0.31 303 364.2030 364.2043 3.6 332.1755, 304.1839, 219.0950(base peak), 177.0480, 145.0418 
1 13/09/19 FL19/0205 
MDMB-4en-PINACA 9.15 896 357 0.16 303 358.2133 358.2131 -0.6 326.1887, 298.1935, 213.1039(base peak), 171.0580, 145.0412 
4F-MDMB-BINACA 9.19 928 363 0.25 303 364.2034 364.2043 2.5 332.1744, 304.1843, 219.0954(base peak), 177.0491, 145.0427 
1 03/09/19 
FL19/206-B MDMB-4en-PINACA 9.14 906 357 0.36 303 358.2132 358.2131 -0.3 326.1877, 298.1936, 213.1046(base peak), 171.0612, 145.0430 
FL19/206-C 
MDMB-4en-PINACA 9.12 883 357 0.16 303 358.2130 358.2131 0.3 326.1878, 298.1941, 213.1039(base peak), 171.0595, 145.0413 
4F-MDMB-BINACA 9.15 899 363 0.21 303 364.2037 364.2043 1.6 332.1771, 304.1831, 219.0942(base peak), 177.0473, 145.0406 
FL19/206-D 
MDMB-4en-PINACA 9.13 868 357 0.21 303 358.2131 358.2131 0.0 326.1875, 298.1927, 213.1040(base peak), 171.0576, 145.0402 
4F-MDMB-BINACA 9.16 930 363 0.22 303 364.2036 364.2043 1.9 332.1778, 304.1840, 219.0948(base peak), 177.0484, 145.0409 
FL19/206-E MDMB-4en-PINACA 9.13 906 357 0.29 303 358.2130 358.2131 0.3 326.1877, 298.1928, 213.1034(base peak), 171.0579, 145.0401 



























MDMB-4en-PINACA 9.12 919 357 0.10 303 358.2129 358.2131 0.6 326.1874, 298.1922, 213.1037(base peak), 171.0601, 145.0421 
4F-MDMB-BINACA 9.16 931 363 0.21 303 364.2035 364.2043 2.2 332.1768, 304.1841, 219.0951(base peak), 177.0485, 145.0430 
FL19/206-G MDMB-4en-PINACA 9.12 891 357 NA 303 358.2126 358.2131 1.4 326.1873, 298.1928, 213.1032(base peak), 171.0571, 145.0400 
1 07/08/19 
FL19/0207-1 5F-MDMB-PICA 10.18 930 376 0.42 292 377.2237 377.2240 0.8 232.1156(base peak), 144.0466 
FL19/0207-2 
5F-MDMB-PICA 10.20 930 376 0.47 292 377.2234 377.2240 1.6 232.1157(base peak), 144.0467 
4F-MDMB-BINACA 9.13 926 363 0.11 303 364.2027 364.2043 4.4 332.1779, 304.1834, 219.0952(base peak), 177.0489, 145.0419 
1 
 18/09/19 FL19/0210 
MDMB-4en-PINACA 9.12 926 357 <0.07 303 358.2130 358.2131 0.3 326.1884, 298.1925, 213.1033(base peak), 171.0575, 145.0404 
4F-MDMB-BINACA 9.15 924 363 0.15 303 364.2033 364.2043 2.7 332.1788, 304.1841, 219.0954(base peak), 177.0482, 145.0416 
5F-MDMB-PICA 10.2 913 376 <0.08 292 377.2236 377.2240 1.1 232.1145(base peak), 144.0449 
1 18/09/19 
FL19/0215-E 
MDMB-4en-PINACA 9.12 903 357 0.13 303 358.2126 358.2131 1.4 326.1883, 298.1933, 213.1036(base peak), 171.0599, 145.0413 
4F-MDMB-BINACA 9.16 948 363 0.19 303 364.2033 364.2043 2.7 332.1768, 304.1843, 219.0942(base peak), 177.0482, 145.0422 
5F-MDMB-PICA 10.11 927 376 <0.08 292 377.2240 377.2240 0.0 232.1150(base peak), 144.0458 
FL19/0215-F 
MDMB-4en-PINACA 9.129 932 357 0.15 303 358.2125 358.2131 1.7 326.1881, 298.1934, 213.1044(base peak), 171.0613, 145.0433 
4F-MDMB-BINACA 9.164 934 363 0.20 303 364.2035 364.2043 2.2 332.1755, 304.1841, 219.0945(base peak), 177.0487, 145.0421 
5F-MDMB-PICA 10.108 924 376 <0.09 292 377.2237 377.2240 0.8 232.1139(base peak), 144.0457 
FL19/0215-G 
MDMB-4en-PINACA 9.118 920 357 0.15 303 358.2127 358.2131 1.1 326.1878, 298.1939, 213.1047(base peak), 171.0604, 145.0437 
4F-MDMB-BINACA 9.152 944 363 0.18 303 364.2035 364.2043 2.2 332.1778, 304.1835, 219.0952(base peak), 177.0486, 145.0418 
FL19/0215-H 
MDMB-4en-PINACA 9.106 909 357 NA 303 358.2119 358.2131 3.3 326.1879, 298.1932, 213.1036(base peak), 171.0593, 145.0402 
  4F-MDMB-BINACA 9.135 912 363 NA 303 364.2029 364.2043 3.8 332.1788, 304.1832, 219.0941(base peak), 177.0478, 145.0404 
1 11/09/19 FL19/0219 MDMB-4en-PINACA 9.124 942 357 0.18 303 358.2126 358.2131 1.4 326.1871, 298.1937, 213.1046(base peak), 171.0580, 145.0423 
1 04/09/19 
FL19/0224-1 
MDMB-4en-PINACA 9.138 922 357 0.29 303 358.2126 358.2131 1.4 326.1871, 298.1935, 213.1036(base peak), 171.0767, 145.0416 
4F-MDMB-BINACA 9.18 941 363 0.44 303 364.2032 364.2043 3.0 332.1739, 304.1843, 219.0955(base peak), 177.0491, 145.0429 
5F-MDMB-PICA 10.09 869 376 <0.10 292 377.2240 377.2240 0.0 232.1138(base peak), 144.0448 
FL19/0224-1 4F-MDMB-BINACA 9.169 943 363 0.36 303 364.2029 364.2043 3.8 332.1742, 304.1841, 219.0943(base peak), 177.0484, 145.0415 
 5F-MDMB-PICA 10.079 802 376 <0.09 292 377.2230 377.2240 2.7 232.1136(base peak), 144.0451 
1 27/09/19 FL19/0226 MDMB-4en-PINACA 9.141 943 357 0.42 303 358.2123 358.2131 2.2 326.1871, 298.1924, 213.1032(base peak), 171.0571, 145.0408 
1 23/09/19 
FL19/0232-2 
MDMB-4en-PINACA 9.107 915 357 0.09 303 358.2127 358.2131 1.1 326.1887, 298.1943, 213.1046(base peak), 171.0596, 145.0423 
4F-MDMB-BINACA 9.135 935 363 0.17 303 364.2037 364.2043 1.6 332.1791, 304.1851, 219.0955(base peak), 177.0495, 145.0424 
FL19/0232-3 4F-MDMB-BINACA 9.114 942 357 0.16 303 364.2039 364.2043 1.1 332.1773, 304.1845, 219.0944(base peak), 177.0480, 145.0408 
1 23/09/19 FL19/0233-1A MDMB-4en-PINACA 9.141 939 357 0.58 303 358.2123 358.2131 2.2 326.1887, 298.1934, 213.1040(base peak), 171.0593, 145.0428 
SECTION 6 
Low energy (6V) ToF-MS and high energy (10-30V) MS/MS spectra for tentative confirmation 
of Cumyl-4CN-BINACA and 4F-PHP identified in seized samples 










(b) HRMS spectrum of 4F-PHP and proposed product ion fragments  
      Example: sample FL19/0003  
 
 
